Dispute Resolved? Ardelyx’s Tenapanor Gets US FDA Panel Nod For Dialysis Patients

 
• By Sue Sutter
Ocean tide
Positive adcomm vote may have turned the tide on tenapanor's approval prospects in chronic kidney disease. • Source: Shutterstock

More from US FDA Performance Tracker

More from Regulatory Trackers